The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair

Nature Genetics

Volumn 37, Issue 9, 2005, Pages 953-957

  Bridge, Wendy L ^a   Vandenberg, Cassandra J ^a   Franklin, Roger J ^a   Hiom, Kevin ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; HELICASE; BRIP1 PROTEIN, HUMAN; CISPLATIN; CROSS LINKING REAGENT; DNA BINDING PROTEIN; FANCD2 PROTEIN, HUMAN; FANCONI ANEMIA GROUP D2 PROTEIN; MITOMYCIN; NUCLEAR PROTEIN; RNA HELICASE; SMALL INTERFERING RNA; UBIQUITIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CHICKEN; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; HOMOZYGOSITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SENSITIVITY ANALYSIS; UBIQUITINATION; ANIMAL; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HELA CELL; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALIA; AVES;

ANIMALS; BRCA1 PROTEIN; CHICKENS; CHROMOSOME ABERRATIONS; CISPLATIN; CROSS-LINKING REAGENTS; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; G2 PHASE; HELA CELLS; HUMANS; MITOMYCIN; NUCLEAR PROTEINS; RNA HELICASES; RNA, SMALL INTERFERING; S PHASE; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 25144503943     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1627     Document Type: Article

References (28)

1. Cantor, S.B. et al. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105, 149-160 (2001).
2. Yu, X., Chini, C.C., He, M., Mer, G. & Chen, J. The BRCT domain is a phospho-protein binding domain. Science 302, 639-642 (2003).
3. Cantor, S. et al. The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. Proc. Natl. Acad. Sci. USA 101, 2357-2362 (2004).
4. Williams, R.S., Lee, M.S., Hau, D.D. & Glover, J.N. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1. Nat. Struct. Mol. Biol. 11, 519-525 (2004).
5. Clapperton, J.A. et al. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer. Nat. Struct. Mol. Biol. 11, 512-518 (2004).
6. Botuyan, M.V. et al. Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains. Structure (Camb.) 12, 1137-1146 (2004).
7. Yu, X. & Chen, J. DNA damage-induced cell cycle checkpoint control requires CtlP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains. Mol. Cell. Biol. 24, 9478-9486 (2004).
8. Manke, I.A., Lowery, D.M., Nguyen, A. & Yaffe, M.B. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302, 636-639 (2003).
9. Shiozaki, E.N., Gu, L., Yan, N. & Shi, Y. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling. Mol. Cell 14, 405-412 (2004).
10. Moynahan, M.E., Chiu, J.W., Koller, B.H.& Jasin, M. Brca1 controls homology-directed DNA repair. Mol. Cell 4, 511-518 (1999).
11. Pierce, A.J., Johnson, R.D., Thompson, L.H. & Jasin, M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev. 13, 2633-2638 (1999).
12. Yarden, R.I., Pardo-Reoyo, S., Sgagias, M., Cowan, K.H. & Brody, L.C. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat. Genet. 30, 285-289 (2002).
13. Xu, B., Kim, S. & Kastan, M.B. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 21, 3445-3450 (2001).
14. Poll, E.H., Arwert, F., Joenje, H. & Eriksson, A.W. Cytogenetic toxicity of antitumor platinum compounds in Fanconi's anemia. Hum. Genet. 61, 228-230 (1982).
15. Simpson, L.J. & Sale, J.E. Rev1 is essential for DNA damage tolerance and non-templated immunoglobulin gene mutation in a vertebrate cell line. EMBO J. 22, 1654-1664 (2003).
16. Yamashita, Y.M. et al. RAD18 and RAD54 cooperatively contribute to maintenance of genomic stability in vertebrate cells. EMBO J. 21, 5558-5566 (2002).
17. Auerbach, A.D. & Wolman, S.R. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature 261, 494-496 (1976).
18. Ishida, R. & Buchwald, M. Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking and alkylating agents. Cancer Res. 42, 4000-4006 (1982).
19. Sasaki, M.S. & Tonomura, A. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. Cancer Res. 33, 1829-1836 (1973).
20. Joenje, H. & Patel, K.J. The emerging genetic and molecular basis of Fanconi anaemia. Nat. Rev. Genet. 2, 446-457 (2001).
21. Niedzwiedz, W. et al. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol. Cell 15, 607-620 (2004).
22. Joenje, H., Arwert, F., Eriksson, A.W., de Koning, H. & Oostra, A.B. Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature 290, 142-143 (1981).
23. Garcia-Higuera, I. et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7, 249-262 (2001).
24. Levitus, M. et al. Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. Blood 103, 2498-2503 (2004).
25. Levitus, M. et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat. Genet., advance online publication 21 August 2005 (doi:10.1038/ng1625).
26. Boardman, P.E. et al. A comprehensive collection of chicken cDNAs. Curr. Biol. 12, 1965-1969 (2002).
27. Arakawa, H., Lodygin, D. & Buerstedde, J.M. Mutant loxP vectors for selectable marker recycle and conditional knock-outs. BMC Biotechnol. 1, 7 (2001).
28. Vandenberg, C.J. et al. BRCA1-independent ubiquitination of FANCD2. Mol. Cell 12, 247-254 (2003).